$DX
DYNEX CAPITAL INC Stock $dx

$dx Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-K Financial Statement

#000082667516000037 Filed on March 08, 2016

Income Statement

Concept	2016 Q1	2014 Q4	2014 Q3
Revenue	$25.10M	$24.30M	$26.00M
YoY Change	4.15%	-15.03%	-17.89%
Cost Of Revenue	$6.300M	$5.700M	$6.100M
YoY Change	16.67%	-32.14%	-29.89%
Gross Profit	$18.80M	$18.60M	$19.90M
YoY Change	0.53%	-7.92%	-13.1%
Gross Profit Margin	74.9%	76.54%	76.54%
Selling, General & Admin	$4.100M	$4.200M	$3.900M
YoY Change	-4.65%	133.33%	8.33%
% of Gross Profit	21.81%	22.58%	19.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$500.0K	$1.900M	$7.000M
YoY Change	-66.67%
% of Gross Profit	2.66%	10.22%	35.18%
Operating Expenses	$4.000M	$4.200M	$2.900M
YoY Change	-4.76%	121.05%	0.0%
Operating Profit	$14.80M	$14.40M	$17.00M
YoY Change	2.07%	-21.31%	-15.0%
Interest Expense	$6.310M	$5.652M	$6.058M
YoY Change	17.48%	71.27%	-30.51%
% of Operating Profit	42.64%	39.25%	35.64%
Other Income/Expense, Net	$87.00K	-$17.00K	$939.0K
YoY Change	20.83%
Pretax Income	-$37.40M	$3.700M	$30.90M
YoY Change	293.68%	-82.87%	-771.74%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings	-$37.43M	$3.700M	$30.87M
YoY Change	295.18%	-82.87%	-767.08%
Net Earnings / Revenue	-149.13%	15.23%	118.72%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.294M	$203.3K	$1.698M
COMMON SHARES
Basic Shares Outstanding	48.95M shares	54.74M shares	54.73M shares
Diluted Shares Outstanding			54.73M shares

Balance Sheet

Concept	2016 Q1	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.90M	$43.90M	$56.60M
YoY Change	115.32%	-36.65%	42.93%
Cash & Equivalents	$82.94M	$43.94M	$56.64M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$28.50M	$28.60M	$48.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$111.4M	$72.50M	$105.0M
YoY Change	58.92%	-30.29%	31.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$98.00K	$4.000M	$3.657B
YoY Change	-99.02%		-12.99%
Other Assets	$86.90M	$42.30M	$32.80M
YoY Change	29.7%	215.67%	107.59%
Total Long-Term Assets	$3.473B	$3.616B	$3.709B
YoY Change	-13.3%	-12.09%	-12.53%
TOTAL ASSETS
Total Short-Term Assets	$111.4M	$72.50M	$105.0M
Total Long-Term Assets	$3.473B	$3.616B	$3.709B
Total Assets	$3.584B	$3.688B	$3.814B
YoY Change	-12.06%	-12.54%	-11.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$2.200M	$1.900M	$1.500M
YoY Change	-4.35%	-24.0%	-37.5%
Deferred Revenue
YoY Change
Short-Term Debt	$2.985B	$3.013B	$3.150B
YoY Change	-6.3%	-15.85%	-14.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.999B	$3.031B	$3.167B
YoY Change	-11.77%	-16.06%	-14.25%
LONG-TERM LIABILITIES
Long-Term Debt	$8.100M	$10.80M	$11.20M
YoY Change	-20.59%	-16.28%	-46.92%
Other Long-Term Liabilities	$92.60M	$39.50M	$20.90M
YoY Change	53.82%	387.65%	-11.06%
Total Long-Term Liabilities	$100.7M	$50.30M	$32.10M
YoY Change	43.04%	139.52%	-28.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.999B	$3.031B	$3.167B
Total Long-Term Liabilities	$100.7M	$50.30M	$32.10M
Total Liabilities	$3.100B	$3.081B	$3.199B
YoY Change	-10.66%	-15.15%	-14.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$380.7M	-$288.2M	-$275.8M
YoY Change	21.61%	14.32%	7.48%
Common Stock	$725.9M	$764.5M	$763.8M
YoY Change	-5.05%	0.31%	0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$483.8M	$607.3M	$614.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.584B	$3.688B	$3.814B
YoY Change	-12.06%	-12.54%	-11.72%

Cashflow Statement

Concept	2016 Q1	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	-$37.43M	$3.700M	$30.87M
YoY Change	295.18%	-82.87%	-767.08%
Depreciation, Depletion And Amortization	$500.0K	$1.900M	$7.000M
YoY Change	-66.67%
Cash From Operating Activities	$53.60M	$54.90M	$54.20M
YoY Change	5.19%	8.07%	-3.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$38.00K	$95.40M	$281.4M
YoY Change	-49.33%	-1.55%	-28.69%
Cash From Investing Activities	$170.6M	$95.40M	$281.4M
YoY Change	-191.13%	-1.55%	-28.69%
FINANCING ACTIVITIES
Cash Dividend Paid	$14.07M
YoY Change	-11.97%
Common Stock Issuance & Retirement, Net	$254.0K
YoY Change	151.49%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$175.2M	-163.0M	-315.6M
YoY Change	-233.93%	38.25%	-28.34%
NET CHANGE
Cash From Operating Activities	$53.60M	54.90M	54.20M
Cash From Investing Activities	$170.6M	95.40M	281.4M
Cash From Financing Activities	-$175.2M	-163.0M	-315.6M
Net Change In Cash	$49.01M	-12.70M	20.00M
YoY Change	-1000.83%	-142.62%	96.08%
FREE CASH FLOW
Cash From Operating Activities	$53.60M	$54.90M	$54.20M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000826675
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48952860	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	376818281	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	DYNEX CAPITAL INC
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	dx	Borrowingsoutstandingwithcounterparty Borrowingsoutstandingwithcounterparty	297916000	USD
CY2015Q4	dx	Dividend Reinvestment Plan Shares Authorized DividendReinvestmentPlanSharesAuthorized	3000000	shares
CY2013	dx	Estimated Rei Ttaxableincome EstimatedREITtaxableincome	71765	USD
CY2014	dx	Estimated Rei Ttaxableincome EstimatedREITtaxableincome	79229	USD
CY2015	dx	Estimated Rei Ttaxableincome EstimatedREITtaxableincome	52964	USD
CY2014Q4	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	868984000	USD
CY2015Q4	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	870102000	USD
CY2015	dx	Notional Amountof Derivative Instruments Added NotionalAmountofDerivativeInstrumentsAdded	3285000000	USD
CY2015	dx	Notional Amountof Derivative Instruments Terminated NotionalAmountofDerivativeInstrumentsTerminated	11130000000	USD
CY2015Q4	dx	Number Of Counterparties Borrowing Availability NumberOfCounterpartiesBorrowingAvailability	32	Agreements
CY2015Q4	dx	Number Of Counterparties Borrowings Outstanding NumberOfCounterpartiesBorrowingsOutstanding	17	Agreements
CY2015Q4	dx	Stock Issued During Period Remaining Shares Available Dividend Reinvestment Plan StockIssuedDuringPeriodRemainingSharesAvailableDividendReinvestmentPlan	2427538	shares
CY2015Q4	dx	Wav Ginterestrateforamountoutstandingwithnamedcounterparty WAVGinterestrateforamountoutstandingwithnamedcounterparty	0.0130
CY2014Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	17525000000	USD
CY2015Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	9680000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	921000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21316000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12768000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	763935000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	725358000	USD
CY2013	us-gaap	Adjustment For Amortization AdjustmentForAmortization	128865000	USD
CY2014	us-gaap	Adjustment For Amortization AdjustmentForAmortization	137837000	USD
CY2015	us-gaap	Adjustment For Amortization AdjustmentForAmortization	152308000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2719000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2965000	USD
CY2014Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	250000	USD
CY2015Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	192000	USD
CY2014Q4	us-gaap	Assets Assets	3688311000	USD
CY2015Q4	us-gaap	Assets Assets	3670048000	USD
CY2014Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0055
CY2015Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0075
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	48868000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	29927000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	23153000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	42033000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3490524000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3505807000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3516239000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3493701000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	3354000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	16223000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-978000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	8670000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	22492000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	3552000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	357892000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	503918000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	449921000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	5316000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	6269000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	4530000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55809000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69330000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43944000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33935000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13521000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-25386000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-10009000	USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2014Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2015Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2015Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2015Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54739111	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49047335	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54310484	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54739111	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49047335	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	547000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	490000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26160000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26532000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26906000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14090000	USD
CY2014Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6234000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73762000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11288000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11511000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11853000	USD
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14640000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26716000	USD
CY2014Q4	us-gaap	Delinquent Amount At End Of Period On Loans Managed And Securitized DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized	2221000	USD
CY2015Q4	us-gaap	Delinquent Amount At End Of Period On Loans Managed And Securitized DelinquentAmountAtEndOfPeriodOnLoansManagedAndSecuritized	1000	USD
CY2014Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2015Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2014Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	440000000	USD
CY2015Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	460000000	USD
CY2014Q4	us-gaap	Derivative Assets DerivativeAssets	5727000	USD
CY2015Q4	us-gaap	Derivative Assets DerivativeAssets	7835000	USD
CY2014Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	4521000	USD
CY2015Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2014Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	1073000	USD
CY2015Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	7835000	USD
CY2014Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	32994000	USD
CY2015Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	32111000	USD
CY2014Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	2494000	USD
CY2015Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	9079000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	5727000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	7835000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	5727000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	7835000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	133000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	0	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	35898000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	41205000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	35898000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	41205000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	410000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	15000	USD
CY2014Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	5727000	USD
CY2013	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-10076000	USD
CY2014Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-13422000	USD
CY2014Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-23074000	USD
CY2014Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	4842000	USD
CY2014Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-21739000	USD
CY2014	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-53393000	USD
CY2015Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-25323000	USD
CY2015Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	17090000	USD
CY2015Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-52749000	USD
CY2015Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	17854000	USD
CY2015	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-43128000	USD
CY2014Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	35898000	USD
CY2015Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	41205000	USD
CY2014Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	35898000	USD
CY2015Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41205000	USD
CY2014Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2015Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2014Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	17085000000	USD
CY2015Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	9220000000	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3049008000	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3150625000	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	410000	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	15000	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	32994000	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	32111000	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3015604000	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3118499000	USD
CY2014Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3049008000	USD
CY2015Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3150625000	USD
CY2014Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	15622000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13709000	USD
CY2015Q4	us-gaap	Due From Officers Or Stockholders DueFromOfficersOrStockholders	9630000	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.10
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.52
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.34
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.52
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.61
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.14
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M27D
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4000000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10835000	USD
CY2014Q4	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate	0	USD
CY2015Q4	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate	520000000	USD
CY2014Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	0	USD
CY2015Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	11475000	USD
CY2014Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3265979000	USD
CY2015Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3361635000	USD
CY2014Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3516239000	USD
CY2015Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3493701000	USD
CY2013	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	3354000	USD
CY2014Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-3307000	USD
CY2014Q2	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-477000	USD
CY2014Q3	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	9057000	USD
CY2014Q4	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	10950000	USD
CY2014	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	16223000	USD
CY2015Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	1308000	USD
CY2015Q2	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-1491000	USD
CY2015Q3	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	113000	USD
CY2015Q4	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-908000	USD
CY2015	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-978000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4119000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3819000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3914000	USD
CY2014Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4155000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4257000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4754000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4379000	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4278000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	835000	USD
CY2013	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1370000	USD
CY2014	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-546000	USD
CY2015	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1607000	USD
CY2013	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-10076000	USD
CY2014	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-53393000	USD
CY2015	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-43128000	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-347000	USD
CY2014	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-600000	USD
CY2015	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-204000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6628000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-381000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2393000	USD
CY2013	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	13346000	USD
CY2014	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	28878000	USD
CY2015	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	8927000	USD
CY2013	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	3503000	USD
CY2014	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	2763000	USD
CY2015	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	1308000	USD
CY2013	us-gaap	Interest Expense InterestExpense	39028000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	7633000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	6572000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	6058000	USD
CY2014Q4	us-gaap	Interest Expense InterestExpense	5652000	USD
CY2014	us-gaap	Interest Expense InterestExpense	25915000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	5371000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	5542000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	5859000	USD
CY2015Q4	us-gaap	Interest Expense InterestExpense	5833000	USD
CY2015	us-gaap	Interest Expense InterestExpense	22605000	USD
CY2013	us-gaap	Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities InterestExpenseBeneficialInterestsIssuedByConsolidatedVariableInterestEntities	926000	USD
CY2014	us-gaap	Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities InterestExpenseBeneficialInterestsIssuedByConsolidatedVariableInterestEntities	94000	USD
CY2015	us-gaap	Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities InterestExpenseBeneficialInterestsIssuedByConsolidatedVariableInterestEntities	98000	USD
CY2015	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	541000	USD
CY2013	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	38102000	USD
CY2014	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	25821000	USD
CY2015	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	22507000	USD
CY2013	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	88104000	USD
CY2014Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	20007000	USD
CY2014Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21146000	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	19942000	USD
CY2014Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18634000	USD
CY2014	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	79729000	USD
CY2015Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18728000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18985000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	20237000	USD
CY2015Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	19689000	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	77639000	USD
CY2013	us-gaap	Interest Income Operating InterestIncomeOperating	127132000	USD
CY2014Q1	us-gaap	Interest Income Operating InterestIncomeOperating	27640000	USD
CY2014Q2	us-gaap	Interest Income Operating InterestIncomeOperating	27718000	USD
CY2014Q3	us-gaap	Interest Income Operating InterestIncomeOperating	26000000	USD
CY2014Q4	us-gaap	Interest Income Operating InterestIncomeOperating	24286000	USD
CY2014	us-gaap	Interest Income Operating InterestIncomeOperating	105644000	USD
CY2015Q1	us-gaap	Interest Income Operating InterestIncomeOperating	24099000	USD
CY2015Q2	us-gaap	Interest Income Operating InterestIncomeOperating	24527000	USD
CY2015Q3	us-gaap	Interest Income Operating InterestIncomeOperating	26096000	USD
CY2015Q4	us-gaap	Interest Income Operating InterestIncomeOperating	25522000	USD
CY2015	us-gaap	Interest Income Operating InterestIncomeOperating	100244000	USD
CY2013	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	123629000	USD
CY2014	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	102881000	USD
CY2015	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	98936000	USD
CY2013	us-gaap	Interest Paid InterestPaid	33517000	USD
CY2014	us-gaap	Interest Paid InterestPaid	19445000	USD
CY2015	us-gaap	Interest Paid InterestPaid	19260000	USD
CY2014Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1947000	USD
CY2015Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1743000	USD
CY2014Q4	us-gaap	Interest Receivable InterestReceivable	21157000	USD
CY2015Q4	us-gaap	Interest Receivable InterestReceivable	22764000	USD
CY2014Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2621540000	USD
CY2015Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2635705000	USD
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7004000	USD
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9509000	USD
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9103000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3081009000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	3178023000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3688311000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3670048000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	283655000	USD
CY2015Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0130
CY2015Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000000	USD
CY2014Q4	us-gaap	Loans And Leases Receivable Consumer Real Estate LoansAndLeasesReceivableConsumerRealEstate	30214000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Consumer Real Estate LoansAndLeasesReceivableConsumerRealEstate	24189000	USD
CY2014Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	39700000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	24145000	USD
CY2015	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-978000	USD
CY2014Q4	us-gaap	Loans Receivable Commercial Real Estate LoansReceivableCommercialRealEstate	9736000	USD
CY2015Q4	us-gaap	Loans Receivable Commercial Real Estate LoansReceivableCommercialRealEstate	148000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	10786000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	8442000	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	3354000	USD
CY2014	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	16223000	USD
CY2014Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	39700000	USD
CY2015Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	24145000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30101000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-664142000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17627000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-165138000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	424205000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209370000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	208760000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	214551000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	216988000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	68069000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	27806000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	16544000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	60167000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3028000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8293000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28572000	USD
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1379000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18630000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11766000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28168000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39271000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30237000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7368000	USD
CY2014Q4	us-gaap	Non Recourse Debt NonRecourseDebt	10967000	USD
CY2015Q4	us-gaap	Non Recourse Debt NonRecourseDebt	8573000	USD
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	89775000	USD
CY2015	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Because the Company incurred an "ownership change" under Section 382 of the Internal Revenue Code ("Section 382"), the Company's ability to utilize its NOL carryforward to offset its taxable income after any required dividend distributions is limited to approximately $13,451 per year with any unused amounts being accumulated and carried forward for use in subsequent years. As of December 31, 2015, the Company had $25,190 of NOL that is not subject to the existing Section 382 limitations available to offset any future taxable income.
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-86327000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	29560000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	35199000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14482000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4855000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	55132000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	23054000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-39679000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27418000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-44877000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34084000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	3354000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	16223000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-978000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-13989000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-6788000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-3499000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	16381000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-113343000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	64567000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-38561000	USD
CY2013	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	7743000	USD
CY2014	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	8900000	USD
CY2015	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5338000	USD
CY2013	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	6054000	USD
CY2014	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	6498000	USD
CY2015	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8565000	USD
CY2014Q4	us-gaap	Other Liabilities OtherLiabilities	3646000	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	3504000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	107000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	225000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	939000	USD
CY2014Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	72000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	632000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-199000	USD
CY2015Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	174000	USD
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	397000	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1046000	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-225000	USD
CY2014Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	7420000	USD
CY2015Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	6193000	USD
CY2013	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	39097000	USD
CY2014	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	11415000	USD
CY2015	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	39929000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-5891000	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	237000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6934000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	41171000	USD
CY2013	us-gaap	Payments Of Dividends PaymentsOfDividends	69332000	USD
CY2014	us-gaap	Payments Of Dividends PaymentsOfDividends	64880000	USD
CY2015	us-gaap	Payments Of Dividends PaymentsOfDividends	61016000	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	545000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	507000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	557000	USD
CY2013	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1419060000	USD
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	599381000	USD
CY2014Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2014Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2014Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	9176000	USD
CY2015Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1122970000	USD
CY2013	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	0	USD
CY2014	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	4000000	USD
CY2015	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	6000000	USD
CY2014Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Loans Receivable Pledged For Other Arrangements PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedForOtherArrangements	11902000	USD
CY2015Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Loans Receivable Pledged For Other Arrangements PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedForOtherArrangements	9220000	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7902000	USD
CY2014Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2015Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2015Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2015Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	9176000	USD
CY2015Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2014Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7861000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7975000	USD
CY2013	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	15828000	USD
CY2014	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	16787000	USD
CY2015	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	15570000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7436000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	177000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	129000	USD
CY2013	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	29176511000	USD
CY2014	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	22547991000	USD
CY2015	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	23555007000	USD
CY2013	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	54251000	USD
CY2014	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2013	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	913210000	USD
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	518303000	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	494275000	USD
CY2013	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-17840000	USD
CY2014	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-2167000	USD
CY2015	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-2395000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	358090000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	503918000	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	449921000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	68069000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	27806000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	16544000	USD
CY2013	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	300000	USD
CY2014	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
CY2015	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	200000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	51190000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288154000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-330713000	USD
CY2014Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3013110000	USD
CY2015Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2589420000	USD
CY2015	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.080
CY2013	us-gaap	Repayments Of Debt RepaymentsOfDebt	29160302000	USD
CY2014	us-gaap	Repayments Of Debt RepaymentsOfDebt	23115878000	USD
CY2015	us-gaap	Repayments Of Debt RepaymentsOfDebt	23458697000	USD
CY2015Q4	us-gaap	Repurchase Agreement Counterparty Amount At Risk RepurchaseAgreementCounterpartyAmountAtRisk	56193000	USD
CY2014	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P88D
CY2015	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P22D
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	42263000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2314000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2719000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2965000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2500000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	994096	shares
CY2014	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	59336	shares
CY2015	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	67296	shares
CY2014	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	16753	shares
CY2015	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	22607	shares
CY2014	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	471210	shares
CY2015	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	263829	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2015	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2016-12-31
CY2015Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	8829000	USD
CY2014	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2015	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5910916	shares
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	607302000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	492025000	USD
CY2013	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	-652000	USD
CY2014	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	208000	USD
CY2015	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	69000	USD
CY2014Q4	us-gaap	Transfers Accounted For As Secured Borrowings Assets Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount	3274597000	USD
CY2015Q4	us-gaap	Transfers Accounted For As Secured Borrowings Assets Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount	2825641000	USD
CY2014Q4	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	3013110000	USD
CY2015Q4	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	2589420000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54648000	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54701000	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52847000	shares
CY2015	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments-Overall (Subtopic 825-10); Recognition and Measurement of Financial Assets and Financial Liabilities, </font><font style="font-family:inherit;font-size:10pt;">which includes the following amendments:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) are to be measured at fair value with changes in fair value recognized in net income.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the exit price notion is to be used by public business entities when measuring the fair value of financial instruments for disclosure purposes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e. securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">elimination of the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measure at amortized cost.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a requirement for the entity to present separately in OCI the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">clarification that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to AFS securities in combination with the entity's other deferred tax assets.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-01 is effective for public companies for fiscal years beginning after December 15, 2017. Management has evaluated this ASU, and its adoption is not expected to have a material impact on the Company's consolidated financial statements.</font></div></div>
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").</font></div></div>
CY2015	us-gaap	Reclassifications Reclassifications	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year's presentation. Because the Company's provision for loan loss was immaterial for the years ended December 31, 2015, 2014, and 2013, this amount is now included within "other income (expense), net" on the Company's consolidated statements of comprehensive income. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.</font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.</font></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0000826675-16-000037-index-headers.html	Edgar Link	pending
0000826675-16-000037-index.html	Edgar Link	pending
0000826675-16-000037.txt	Edgar Link	pending
0000826675-16-000037-xbrl.zip	Edgar Link	pending
a2015form10-k.htm	Edgar Link	pending
a2015form10-kexx1017execof.htm	Edgar Link	pending
a2015form10-kexx1018direct.htm	Edgar Link	pending
a2015form10-kexx211console.htm	Edgar Link	pending
a2015form10-kexx231consent.htm	Edgar Link	pending
a2015form10-kexx311ceocert.htm	Edgar Link	pending
a2015form10-kexx312cfocert.htm	Edgar Link	pending
a2015form10-kexx321soxcert.htm	Edgar Link	pending
a2015form10-_chartx00321.jpg	Edgar Link	pending
a2015form10-_chartx02898.jpg	Edgar Link	pending
a2015form10-_chartx50677.jpg	Edgar Link	pending
a2015form10-_chartx50867.jpg	Edgar Link	pending
a2015form10-_chartx52759.jpg	Edgar Link	pending
a2015form10-_chartx53666.jpg	Edgar Link	pending
a2015form10-_chartx54575.jpg	Edgar Link	pending
a2015form10-_chartx55472.jpg	Edgar Link	pending
a2015form10-_chartx56536.jpg	Edgar Link	pending
a2015form10-_chartx57517.jpg	Edgar Link	pending
a2015form10-_chartx58424.jpg	Edgar Link	pending
a2015form10-_chartx59310.jpg	Edgar Link	pending
a3q15form10-_chartx19922a01.jpg	Edgar Link	pending
a3q15form10-_chartx21607a01.jpg	Edgar Link	pending
dx-20151231.xml	Edgar Link	completed
dx-20151231.xsd	Edgar Link	pending
dx-20151231_cal.xml	Edgar Link	unprocessable
dx-20151231_def.xml	Edgar Link	unprocessable
dx-20151231_lab.xml	Edgar Link	unprocessable
dx-20151231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DX
DYNEX CAPITAL INC Stock $dx

2016 Q1 Form 10-K Financial Statement

#000082667516000037 Filed on March 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX DYNEX CAPITAL INC Stock $dx

2016 Q1 Form 10-K Financial Statement

#000082667516000037 Filed on March 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX
DYNEX CAPITAL INC Stock $dx